Industry
Featured experience
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Charles River Laboratories cooperation agreement with Elliott
We are advising Charles River on the agreement
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Invacare chapter 11 plan confirmed
We advised the prepetition term loan agent and escrow agent on the transaction
MedSci Healthcare Holdings HK$608 million IPO
We advised MedSci on its IPO and HKEX listing
IDEAYA Biosciences $201 million equity offering
The common stock is listed on the Nasdaq Global Select Market
Diagnósticos da América R$1.7 billion equity offering
The common shares and the warrants are listed on the São Paulo Stock Exchange
Gamida Cell $23 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
AN2 Therapeutics $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
AVITA Medical at-the-market offering
The stock is listed on the Nasdaq Global Market
InflaRx follow-on offering
The shares are listed on the Nasdaq Global Market
Medtronic Global Holdings $2 billion notes offering
The investment-grade offering comprises two tranches of notes
Intercept Pharmaceuticals $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market